Observation of pregnant women (PW) after severe pneumonia (P) with influenza A/H1N1 virus infection in 2009-2010: Long-term results Source: Annual Congress 2011 - Influenza A (H1N1): lessons after the epidemic Year: 2011
Underlying clinical conditions and invasive pneumococcal disease (IPD) in adults in Spain (ODIN study, 2010-2012) Source: Annual Congress 2013 –Recent developments in pneumonia Year: 2013
RSV hospitalization in Down syndrome in the Canadian Registry of Synagis (CARESS) following prophylaxis (2006-2011) Source: Annual Congress 2012 - New insights into respiratory infections in children Year: 2012
Plaque-related vs. plaque-unrelated cardio and cerebrovascular events (CCVE) in hospitalized patients with community-acquired pneumonia (CAP): Preliminary results from the FAILCAP study (ClinicalTrials: NCT01143155) Source: International Congress 2014 – Immunology of respiratory infections Year: 2014
Definition of severity and the reasons for hospitalization (RH) in patients with community-acquired pneumonia (CAP) Source: Eur Respir J 2005; 26: Suppl. 49, 641s Year: 2005
Hospitalization, mortality and vaccine effectiveness in a group of chronic obstructive pulmonary disease (COPD) patients during influenza season 1999 - 2000 Source: Eur Respir J 2001; 18: Suppl. 33, 209s Year: 2001
RSV hospitalization in cystic fibrosis in the Canadian registry of palivizumab (CARESS) following prophylaxis (2005-2012) Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children Year: 2013
Risk factors that determine time to first RSV hospitalization in CARESS: The Canadian registry of palivizumab (2005-2011) Source: Annual Congress 2012 - Epidemiology of various respiratory diseases Year: 2012
Use of pneumonia severity index in Spain to decide hospitalization among patients with community-acquired pneumonia (CAP). (Nacar Study) Source: Eur Respir J 2005; 26: Suppl. 49, 637s Year: 2005
Late Breaking Abstract: Results of the first year of the "population-based nationwide surveillance of invasive pneumococcal disease (IPD) among adults >50 years old in Belgium" (2009-2010) Source: Annual Congress 2010 - Aetiology of lower respiratory tract infections and treatment in special situations Year: 2010
Can procalcitonin (PCT) be an indicator of viral severe community-acquired pneumonia (CAP) based on epidemics of influenza H1N1 in season 2015-2016? Source: International Congress 2016 – Viral infections in different respiratory conditions: from the bedside to the lab Year: 2016
CRAX index for prediction of morbidity among hospitalized patients with Influenza (A) H1N1 infection Source: Virtual Congress 2021 – Fungi, viruses, parasites and the immunocompromised Year: 2021
Influence of comorbidities in the clinical presentation of invasive pneumococcal disease (IPD) in adults in Spain, 2010-2013. The ODIN study Source: International Congress 2014 – The epidemiology of respiratory infections and lung cancer Year: 2014
Severe community-acquired pneumonia (S-CAP) in patients aged ≤65 years-old without comorbidities (NOCOM) Source: Annual Congress 2009 - Ventilator-associated pneumonia, severe community-acquired pneumonia and healthcare associated pneumonia Year: 2009
The burden of hospitalized all-cause and pneumococcal pneumonia in Spain (2010) Source: Annual Congress 2013 –Epidemiology of respiratory disease Year: 2013
Severe community-acquired pneumonia (SCAP) in pregnant and postpartum women with or without swine-origin influenza A (H1 N1 ) virus (SOIV) Source: Annual Congress 2010 - Influenza A (H1N1): characteristics, risk factors and prognosis Year: 2010
Cryptogenic organizing pneumonia in Spain. Study of 309 patients (1985-2002) Source: Eur Respir J 2004; 24: Suppl. 48, 535s Year: 2004
Site of care for community-acquired pneumonia (CAP) patients with CRB-65 score of 0-1 and pneumonia severity index (PSI) risk class (RC) of IV-V: what to do when this discrepancy occurs. Results from the CAPO international study Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia Year: 2008
Surfactant protein D (SPD) like marker of effectiveness ofphosphatidylcholine treatment outcomes in patients (pts) with community acquired pneumonia (CAP) Source: International Congress 2015 – Healthcare organisation and appropriateness in lung disorders Year: 2015
The pneumonia severity index (PSI) do not underestimate the severity of community-acquired pneumonia (CAP) in young patients: results from the CAPO international study Source: Annual Congress 2008 - Factors related to outcome of community-acquired pneumonia Year: 2008